Search

Objective: Telehealth is used in various healthcare settings with patient satisfaction and reduced patient cost. [1, 2] However, fertility care is a uniquely personal journey and patient attitudes towards telehealth are relatively unknown. We evaluated attitudes of fertility patients across the United States towards telehealth using a validated telehealth satisfaction and usefulness questionnaire. Materials and Methods: We conducted a cross-sectional survey study. An anonymous, web-based survey was distributed to national infertility groups between Feb-April 2021.The survey gathered demographic information and included the Telehealth Usability Questionnaire (TUQ), which assesses aspects of telehealth usability with a 7-point Likert scale (strongly disagree to strongly agree). We solicited general comments regarding telehealth for fertility care. The primary outcome was overall satisfaction using telehealth. We computed descriptive statistics to compare satisfied vs unsatisfied participants. Results: 104 respondents initiated and 74 completed the survey. Participants represented 24 different states and all regions of the United States. Most respondents were white (81.1%) with a median age of 35 years old. Most participants (80%) were satisfied using telehealth. Given low frequency of patient dissatisfaction, we were unable to perform statistical tests to compare demographic differences between satisfied and unsatisfied participants. Most (86.5%) respondents would use telehealth again. When given an option, 63.5% prefer in person for new patient visits. For follow up visits, 47.3% prefer telehealth and 27% had no preference. Only 25.7% preferred a follow up visit in person. Conclusions: Telehealth can improve access to care with high rates of patient satisfaction. Most fertility patients still prefer new visits be conducted in person. Impact Statement: Our findings suggest fertility clinics should continue to offer telehealth visits even after the end of the COVID-19 pandemic. References: 1. Alex Zhu, D., et al., TELEHEALTH FOR MALE-INFERTILITY IS FEASIBLE AND SAVES PATIENTS’ TIME AND MONEY. ASRM 2020 2. Tenforde, A.S., et al., Outpatient Physical, Occupational, and Speech Therapy Synchronous Telemedicine: A Survey Study of Patient Satisfaction with Virtual Visits During the COVID-19 Pandemic. Am J Phys Med Rehabil, 2020.

The purpose of this review is to educate the reader on the role that cryopreservation has played and continues to play in the ever-evolving field of assisted reproductive technologies, specifically in clinical human fertility treatment. We discuss the science behind the cryopreservation methods and investigated some of the major considerations that any clinic or cryobank faces in terms of risks and liabilities, physical challenges that accompany the constantly growing collection of cryopreserved specimens, and what this means on the ethical and legal front. Finally, we take a glimpse in the future to explore what may be on the horizon for the preservation of gametes and reproductive tissues.

Women with early menopause or primary ovarian insufficiency (POI) experience a menopausal state a decade or more earlier than their peers. The health consequences for POI are vast and varied with detrimental effects seen on neurological, psychological, bone, and cardiovascular systems. The risk profile of POI patients requires special attention, as they differ from a typical menopausal population. This review will explore the health risks associated with POI and examine the various treatment options and also the risks associated with hormone therapy. Given the risks and benefits, POI patients should be strongly encouraged to start hormone therapy until the median age of menopause.